Global Closed System Drug Transfer Device (CSTD) Market Growth to be Propelled by Need to Comply with the Health and Safety Standards by CAGR of ~20% During 2022 – 2031
Kenneth Research published a report titled “Closed System Drug Transfer Device (CSTD) Market: Global Demand Analysis &
Opportunity Outlook 2031” which
delivers detailed overview of the global closed system drug transfer
device (CSTD) market in terms of market segmentation by technology, type,
end-users, and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The global closed system drug transfer device (CSTD) market is estimated to grow at a CAGR of ~20 % over the forecast
period, i.e., 2022-2031. The market is segmented by end-users
into academic &
research institutes, hospitals & clinics, oncology centers, and others. Out
of these, the hospitals & clinics segment is anticipated to hold the
largest share in the global closed
system drug transfer device (CSTD) market by the end of 2031 owing to the financial capability
of hospitals to purchase CSTD. Furthermore, there are a high number of cancer
patients receiving treatment at hospitals, thereby contributing to the growth
of the segment.
There is a need to
comply with the health and safety standards of healthcare workers for treating
their patients. Furthermore, the CSTD
is used to transfer the drugs to patients in a controlled manner to avoid any
kind of mishandling. Therefore, it is expected to drive the growth of the
global closed system drug transfer device (CSTD) market.
Geographically,
the global closed system drug transfer
device (CSTD) market is segmented into five
major regions including North America, Europe, Asia Pacific, Latin America and
Middle East & Africa region. Out of them, the market in the Asia Pacific
region is estimated to hold the noteworthy growth by
the end of 2031 owing to the rise in cancer cases and an increase in the
population base.
The
research is global in nature and covers detailed analysis on the market in
North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden,
Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE,
Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment opportunities,
demand for future outlook etc. has also been covered and displayed in the
research report.
Increase in the Use of Antineoplastic Drugs to
Drive the Growth of the Market
According to the International Agency for
Research on Cancer, the number of new cancer diagnoses was 19.3 million in
2020, with 10.0 million fatalities.
There is an increase in the use of antineoplastic
drugs that are hazardous for the treatment of patients suffering from cancer.
Therefore, closed system drug transfer device is used to protect the patients
from any mishappening while the healthcare workers are transferring drugs to
patient’s body. Hence, the increase in
the use of antineoplastic drugs is anticipated to increase the growth of the global
closed system drug transfer device (CSTD) market.
However,
high cost of CSTD and lack of awareness among healthcare workers are expected to operate as key
restraint to the growth of global closed system drug transfer device (CSTD)
market over the forecast period.
This
report also provides the existing competitive scenario of some of the key
players of the global closed system drug transfer device (CSTD) market which
includes company profiling of Becton,
Dickinson and Company, EquashieldMedical Ltd., Corvida Medical, Baxter
International, Inc., ICU Medical, Inc., Caragen Ltd, Yukon Medical, Vygon,
Simplivia Healthcare Ltd., Teva Pharmaceutical Industries Ltd., and others.
The profiling enfolds key information of the companies which encompasses
business overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the global
closed system drug transfer device (CSTD) market that will help industry
consultants, equipment manufacturers, existing players searching for expansion
opportunities, new players searching possibilities and other stakeholders to
align their market centric strategies according to the ongoing and expected trends
in the future.
Request Report Sample@https://www.kennethresearch.com/sample-request-10085885
Kenneth Research is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: sales@kennethresearch.com
U.S. Phone: +1 313 462 0609
Comments
Post a Comment